Last reviewed · How we verify

NCT05518175: POPS

Patient-centered Outcomes After Permanent Female Sterilization Procedure(POPS Trial)

Completed NA Last updated 26 January 2026
What this trial tests

NA trial testing Traditional laparoscopy in Sterility, Female in 255 participants. Completed in 5 June 2025.

Timeline
15 November 2022
Primary endpoint
7 March 2025
5 June 2025

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment255
Start date15 November 2022
Primary completion7 March 2025
Estimated completion5 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 55, female only, with Sterility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare and capture key elements of the patient experience, quality of recovery, preferences and satisfaction after laparoscopic salpingectomy done via 3 different routes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sterility, Female

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05518175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing